{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Aspira Women's Health Inc."},"Symbol":{"label":"Symbol","value":"AWH"},"Address":{"label":"Address","value":"12117 BEE CAVES ROAD SUITE 100, BUILDING III, AUSTIN, Texas, 78738, United States"},"Phone":{"label":"Phone","value":"+1 512 519-0400"},"Industry":{"label":"Industry","value":"Medical/Dental Instruments"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. Aspira GenetiX testing offers both targeted and more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment."},"CompanyUrl":{"label":"Company Url","value":"https://www.aspirawh.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Charles J. Dunton","title":"Chief Medical Officer"},{"name":"Justin DeGrazia","title":"Senior Director-Research &amp; Development"},{"name":"Nicole Sandford","title":"President, Chief Executive Officer &amp; Director"},{"name":"Ryan Phan","title":"Chief Operating &amp; Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}